A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling
Molecular Cell · 2023
DOI: 10.1016/j.molcel.2023.06.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023. Verfasst von Jianong Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of Urology, Shanghai General…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
N6-methyladenosine (m6A) of mRNAs modulated by the METTL3-METTL14-WTAP-RBM15 methyltransferase complex and m6A demethylases such as FTO play important roles in regulating mRNA stability, splicing, and translation. Here, we demonstrate that FTO-IT1 long noncoding RNA (lncRNA) was upregulated and positively correlated with poor survival of patients with wild-type p53-expressing prostate cancer (PCa). m6A RIP-seq analysis revealed that FTO-IT1 knockout increased mRNA m6A methylation of a subset of p53 transcriptional target genes (e.g., FAS, TP53INP1, and SESN2) and induced PCa cell cycle arrest and apoptosis. We further showed that FTO-IT1 directly binds RBM15 and inhibits RBM15 binding, m6A methylation, and stability of p53 target mRNAs. Therapeutic depletion of FTO-IT1 restored mRNA m6A level and expression of p53 target genes and inhibited PCa growth in mice. Our study identifies FTO-IT1 lncRNA as a bona fide suppressor of the m6A methyltransferase complex and p53 tumor suppression signaling and nominates FTO-IT1 as a potential therapeutic target of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100 H…
- Department of Chemistry, Department of Biochemistry and Molecular Biology, and Institute for Biophysical Dynamics, The University of Chicago, 929 East 57th Street, Chicago, IL 60637, USA; Howard Hughes Medical Institute…
- Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
- Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang 212002, China.
- Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
- Howard Hughes Medical Institute
Zitieren
APA
Zhang, J., Wei, J., Sun, R., Sheng, H., Yin, K., Pan, Y., Jimenez, R., Chen, S., Cui, X. L., Zou, Z., Yue, Z., Emch, M. J., Hawse, J. R., Wang, L., He, H. H., Xia, S., Han, B., He, C., & Huang, H. (2023). A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling. Molecular Cell. https://doi.org/10.1016/j.molcel.2023.06.024
Vancouver
Zhang J, Wei J, Sun R, Sheng H, Yin K, Pan Y, et al. A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling. Molecular Cell. 2023. doi:10.1016/j.molcel.2023.06.024
BibTeX
@article{Zhang2023,
author = {Zhang, Jianong and Wei, Jiangbo and Sun, Rui and Sheng, Haoyue and Yin, Kai and Pan, Yunqian and Jimenez, Rafael and Chen, Sujun and Cui, Xiao-Long and Zou, Zhongyu and Yue, Zhiying and Emch, Michael J and Hawse, John R and Wang, Liguo and He, Housheng Hansen and Xia, Shujie and Han, Bangmin and He, Chuan and Huang, Haojie},
title = {A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling},
journal = {Molecular Cell},
year = {2023},
doi = {10.1016/j.molcel.2023.06.024}
}
EUVIMED